|
Volumn 2, Issue 3, 2000, Pages 263-270
|
Fenretinide and cancer prevention.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FENRETINIDE;
ANIMAL;
BREAST TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
FEMALE;
HUMAN;
MALE;
NEOPLASM;
OVARY TUMOR;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ANIMALS;
ANTICARCINOGENIC AGENTS;
BREAST NEOPLASMS;
FEMALE;
FENRETINIDE;
HUMANS;
MALE;
NEOPLASMS;
OVARIAN NEOPLASMS;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 0034188790
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-000-0077-x Document Type: Review |
Times cited : (20)
|
References (53)
|